|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.78 USD | +0.59% |
|
-1.64% | +7.63% |
| 10/07 | GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial | AN |
| 10/07 | GSK, Hansoh's targeted cancer drug hits main survival goal in China trial | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.33% | -2.09% | +4.59% | +26.52% | +10.60% | +50.33% | +162.29% | +405.80% | +1,392.07% | 1,060B | |
| -0.82% | -2.30% | +7.75% | +7.77% | +24.17% | +62.97% | +61.11% | +51.39% | +109.18% | 619B | |
| -0.73% | -4.98% | +10.28% | +19.30% | +8.57% | +27.22% | +84.46% | +112.80% | +286.66% | 438B | |
| +0.33% | -1.17% | +3.92% | +6.65% | +2.56% | +27.98% | +26.90% | -4.67% | +32.26% | 333B | |
| -0.02% | -2.85% | +4.40% | +2.07% | +13.39% | +25.27% | +44.88% | +46.32% | +53.81% | 282B | |
| -3.89% | -11.22% | -4.68% | -15.73% | -6.93% | +20.78% | +26.07% | +48.40% | +180.59% | 267B | |
| +0.66% | -1.42% | +13.83% | +33.91% | -0.92% | -29.26% | -39.30% | +18.34% | +75.52% | 218B | |
| -0.06% | -2.88% | +7.60% | +3.52% | +11.02% | +20.98% | +61.70% | +48.20% | +125.57% | 196B | |
| -3.72% | -1.10% | +6.87% | -6.59% | +5.78% | +13.35% | +71.53% | +90.31% | +50.01% | 161B | |
| -0.33% | -0.62% | -5.59% | -10.22% | -2.93% | -6.25% | -32.26% | -38.98% | -33.08% | 138B | |
| -2.24% | -8.08% | +11.40% | +11.26% | +7.07% | +1.22% | +40.91% | +144.95% | +445.63% | 123B | |
| -0.62% | -0.95% | +3.56% | -1.77% | +6.75% | +18.67% | -7.84% | -14.26% | -23.51% | 118B | |
| -0.33% | +0.55% | +0.29% | -4.94% | -7.85% | -9.42% | -19.17% | -12.60% | +2.75% | 105B | |
| +0.41% | -3.31% | -2.26% | -14.82% | -10.36% | +7.73% | +93.03% | +79.17% | +502.36% | 75.29B | |
| -1.14% | -6.07% | +41.70% | +24.93% | +35.42% | +80.42% | +1.18% | -1.40% | -44.87% | 56.29B | |
| +0.25% | +2.39% | +18.59% | -2.30% | -6.41% | -3.21% | +17.10% | -10.23% | +270.52% | 54.27B | |
| -0.72% | 0.00% | +5.70% | -6.51% | +10.84% | +23.59% | +21.57% | +47.06% | +26.01% | 52.42B | |
| +0.44% | -0.69% | +7.01% | -0.63% | -3.47% | -2.79% | +16.18% | - | - | 42.8B | |
| -4.49% | -4.48% | +2.59% | -7.25% | -24.87% | -7.40% | +49.52% | +69.04% | +380.48% | 39.89B | |
| Average | -0.86% | -2.64% | +7.24% | +3.43% | +3.81% | +16.96% | +35.78% | +59.98% | +212.88% | 230.42B | |
| Weighted average by Cap. | -0.60% | -2.84% | +5.95% | +10.45% | +8.30% | +30.23% | +68.51% | +134.67% | +439.73% |
- Stock Market
- Stocks
- GSK Stock
- GSK Stock
- Sector GSK plc
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
